These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15992117)

  • 1. Imidazoline receptors: new targets for antihyperglycaemic drugs.
    Morgan NG
    Expert Opin Investig Drugs; 1999 May; 8(5):575-84. PubMed ID: 15992117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imidazoline binding sites in the endocrine pancreas: can they fulfil their potential as targets for the development of new insulin secretagogues?
    Morgan NG; Chan SL
    Curr Pharm Des; 2001 Sep; 7(14):1413-31. PubMed ID: 11472276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of the imidazoline receptors in toxicology.
    Lowry JA; Brown JT
    Clin Toxicol (Phila); 2014 Jun; 52(5):454-69. PubMed ID: 24666288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does a second generation of centrally acting antihypertensive drugs really exist?
    Feldman J; Greney H; Monassier L; Vonthron C; Bruban V; Dontenwill M; Bousquet P
    J Auton Nerv Syst; 1998 Oct; 72(2-3):94-7. PubMed ID: 9851557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imidazolines and pancreatic hormone secretion.
    Morgan NG; Chan SL; Mourtada M; Monks LK; Ramsden CA
    Ann N Y Acad Sci; 1999 Jun; 881():217-28. PubMed ID: 10415920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imidazoline/guanidinium binding sites and their relation to inhibition of K(ATP) channels in pancreatic B-cells.
    Rustenbeck I; Herrmann C; Ratzka P; Hasselblatt A
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):410-7. PubMed ID: 9303581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of imidazoline binding site ligands on the growth and viability of clonal pancreatic beta-cells.
    Mourtada M; Elliott J; Smith SA; Morgan NG
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):146-54. PubMed ID: 10685869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with sigma receptors.
    Chan SL; Pallett AL; Clews J; Ramsden CA; Morgan NG
    Eur J Pharmacol; 1997 Apr; 323(2-3):241-4. PubMed ID: 9128845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites.
    Chan SL; Brown CA; Scarpello KE; Morgan NG
    Br J Pharmacol; 1994 Aug; 112(4):1065-70. PubMed ID: 7952865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between imidazoline and alpha2-adrenoceptors involved in the sympatho-inhibitory actions of centrally acting antihypertensive agents.
    Head GA; Chan CK; Burke SL
    J Auton Nerv Syst; 1998 Oct; 72(2-3):163-9. PubMed ID: 9851565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imidazoline binding sites and receptors in cardiovascular tissue.
    Molderings GJ; Göthert M
    Gen Pharmacol; 1999 Jan; 32(1):17-22. PubMed ID: 9888248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.
    Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R
    Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors?
    Zonnenchein R; Diamant S; Atlas D
    Eur J Pharmacol; 1990 Nov; 190(1-2):203-15. PubMed ID: 1981751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I1 receptors, cardiovascular function, and metabolism.
    Bousquet P
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):317S-321S. PubMed ID: 11721890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible structural and functional relationships between imidazoline receptors and alpha 2-adrenoceptors.
    Hieble JP; Ruffolo RR
    Ann N Y Acad Sci; 1995 Jul; 763():8-21. PubMed ID: 7677390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of imidazoline derivatives on cholinergic motility in guinea-pig ileum: involvement of presynaptic alpha2-adrenoceptors or imidazoline receptors?
    Colucci R; Blandizzi C; Carignani D; Placanica G; Lazzeri G; Del Tacca M
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):682-91. PubMed ID: 9686946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.
    Olmos G; Kulkarni RN; Haque M; MacDermot J
    Eur J Pharmacol; 1994 Sep; 262(1-2):41-8. PubMed ID: 7813577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R.
    Bleck C; Wienbergen A; Rustenbeck I
    Diabetologia; 2005 Dec; 48(12):2567-75. PubMed ID: 16283242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of I1-imidazoline receptors using microphysiometry and molecular modelling.
    Musgrave IF; Hughes RA
    J Auton Nerv Syst; 1998 Oct; 72(2-3):137-46. PubMed ID: 9851562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel targets and techniques in imidazoline receptor research.
    Musgrave IF; Hughes RA
    Ann N Y Acad Sci; 1999 Jun; 881():301-12. PubMed ID: 10415931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.